JP2015518827A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015518827A5 JP2015518827A5 JP2015512727A JP2015512727A JP2015518827A5 JP 2015518827 A5 JP2015518827 A5 JP 2015518827A5 JP 2015512727 A JP2015512727 A JP 2015512727A JP 2015512727 A JP2015512727 A JP 2015512727A JP 2015518827 A5 JP2015518827 A5 JP 2015518827A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence number
- sequence
- variable region
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648391P | 2012-05-17 | 2012-05-17 | |
| US61/648,391 | 2012-05-17 | ||
| PCT/US2013/040827 WO2013173255A2 (en) | 2012-05-17 | 2013-05-13 | Antigen binding proteins that bind egfr |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015518827A JP2015518827A (ja) | 2015-07-06 |
| JP2015518827A5 true JP2015518827A5 (OSRAM) | 2016-06-30 |
| JP6441792B2 JP6441792B2 (ja) | 2018-12-19 |
Family
ID=49581478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015512727A Expired - Fee Related JP6441792B2 (ja) | 2012-05-17 | 2013-05-13 | Ｅｇｆｒに結合する抗原結合蛋白質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9944707B2 (OSRAM) |
| EP (1) | EP2850105A4 (OSRAM) |
| JP (1) | JP6441792B2 (OSRAM) |
| CN (1) | CN104918956A (OSRAM) |
| CA (1) | CA2872018A1 (OSRAM) |
| HK (1) | HK1208474A1 (OSRAM) |
| WO (1) | WO2013173255A2 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10100118B2 (en) | 2015-04-08 | 2018-10-16 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind CD123 |
| JP2018513856A (ja) * | 2015-04-08 | 2018-05-31 | ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | Ｃｄ１２３に結合する抗体治療剤 |
| BR112018012352A2 (pt) * | 2015-12-16 | 2018-12-11 | Merck Sharp & Dohme Corp. | anticorpos anti-lag3 e fragmentos de ligação ao antígeno |
| MA43660A (fr) | 2016-01-22 | 2018-11-28 | Adimab Llc | Anticorps anti-facteur xi de coagulation |
| HUE058745T2 (hu) * | 2016-04-27 | 2022-09-28 | Green Cross Corp | Hatóanyagként epidermális növekedési faktor receptorhoz specifikusan kötõdõ antitestet tartalmazó gyógyászati készítmény rák áttételének gátlására |
| TWI752964B (zh) | 2016-06-14 | 2022-01-21 | 美商默沙東藥廠 | 抗凝血因子ｘｉ抗體 |
| JP7302028B2 (ja) * | 2019-06-04 | 2023-07-03 | アカデミア シニカ | 上皮成長因子受容体を標的とするリガンド、及び腫瘍を治療するための組成物 |
| WO2021035096A1 (en) * | 2019-08-20 | 2021-02-25 | Kumquat Biosciences Inc. | Compositions and methods for targeting cellular molecules |
| EP4347643A4 (en) * | 2021-05-27 | 2025-09-17 | Us Gov Veterans Affairs | HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO STREPTOLYSIN O AND METHODS OF USE |
| EP4473018A2 (en) * | 2022-02-04 | 2024-12-11 | Vivasor, Inc. | Antigen binding proteins that bind b7-h3 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL181342B1 (pl) | 1994-03-17 | 2001-07-31 | Merck Patent Gmbh | Jednolancuchowe anty-EGFR Fv i przeciwciala anty-EGFR, czasteczka DNA, sposoby wytwarzania jednolancuchowego przeciwciala anty-EGFR i przeciwciala anty-EGFR oraz kompozycja farmaceutyczna PL PL PL PL PL PL PL |
| ES2301183T3 (es) | 1996-12-03 | 2008-06-16 | Amgen Fremont Inc. | Anticuerpo completamente humano que se une al receptor del egfr. |
| US6235883B1 (en) | 1997-05-05 | 2001-05-22 | Abgenix, Inc. | Human monoclonal antibodies to epidermal growth factor receptor |
| US20020173629A1 (en) * | 1997-05-05 | 2002-11-21 | Aya Jakobovits | Human monoclonal antibodies to epidermal growth factor receptor |
| DE60042693D1 (de) | 1999-08-27 | 2009-09-17 | Genentech Inc | Dosierung für die behandlung mit anti erbb2-antikörpern |
| US7595378B2 (en) | 2001-06-13 | 2009-09-29 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| RU2335507C2 (ru) | 2001-06-13 | 2008-10-10 | Генмаб А/С | Человеческие моноклональные антитела к рецептору эпидермального фактора роста (egfr), способ их получения и их использование, гибридома, трансфектома, трансгенное животное, экспрессионный вектор |
| RU2402569C2 (ru) | 2004-03-19 | 2010-10-27 | Имклоун Элэлси | Человеческие антитела к рецептору эпидермального фактора роста |
| CN101233155B (zh) * | 2004-03-19 | 2013-06-19 | 英克隆有限责任公司 | 人抗表皮生长因子受体抗体 |
| WO2006082515A2 (en) * | 2005-02-07 | 2006-08-10 | Glycart Biotechnology Ag | Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof |
| US20060216288A1 (en) | 2005-03-22 | 2006-09-28 | Amgen Inc | Combinations for the treatment of cancer |
| ATE461220T1 (de) * | 2005-11-12 | 2010-04-15 | Lilly Co Eli | Anti-egfr-antikörper |
| WO2009012181A2 (en) | 2007-07-13 | 2009-01-22 | Ventana Medical Systems, Inc. | Method of identifying diagnostic reagents |
| MX2011003133A (es) | 2008-09-26 | 2011-04-21 | Roche Glycart Ag | Anticuerpos biespecificos anti-egfr/anti-igf-1r. |
| US20110287112A1 (en) | 2009-01-30 | 2011-11-24 | Ono Pharmaceutical Co., Ltd. | Prostate cancer progression inhibitor and progression inhibition method |
| CA2754646A1 (en) | 2009-03-31 | 2010-10-07 | Roche Glycart Ag | Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan |
| US8658175B2 (en) | 2009-10-28 | 2014-02-25 | Abbvie Biotherapeutics Inc. | Anti-EGFR antibodies and their uses |
| JP5818003B2 (ja) | 2009-11-18 | 2015-11-18 | 国立大学法人東北大学 | ヒト型化抗ｅｇｆｒ抗体可変領域の高機能性変異体 |
| WO2011156617A2 (en) | 2010-06-09 | 2011-12-15 | Aveo Pharmaceuticals, Inc. | Anti-egfr antibodies |
| EP2632490A4 (en) | 2010-10-29 | 2014-10-22 | Immunogen Inc | NOVEL MOLECULES BINDING TO THE EGF RECEPTOR AND IMMUNOCONJUGATES THEREOF |
| US8691231B2 (en) | 2011-06-03 | 2014-04-08 | Merrimack Pharmaceuticals, Inc. | Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies |
| TWI443108B (zh) | 2011-12-28 | 2014-07-01 | Ind Tech Res Inst | 抗人類表皮生長因子受體抗體及其應用 |
-
2013
- 2013-05-13 JP JP2015512727A patent/JP6441792B2/ja not_active Expired - Fee Related
- 2013-05-13 CN CN201380038496.5A patent/CN104918956A/zh active Pending
- 2013-05-13 US US13/893,312 patent/US9944707B2/en active Active
- 2013-05-13 WO PCT/US2013/040827 patent/WO2013173255A2/en not_active Ceased
- 2013-05-13 HK HK15109023.5A patent/HK1208474A1/xx unknown
- 2013-05-13 EP EP13790813.3A patent/EP2850105A4/en not_active Withdrawn
- 2013-05-13 CA CA2872018A patent/CA2872018A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6829330B2 (ja) | Ｐｄ−ｌ１に結合する抗原結合蛋白質 | |
| JP6997743B2 (ja) | Ｐｄ－１に結合する抗原結合蛋白質 | |
| US11919952B2 (en) | Antigen binding proteins that bind PD-L1 | |
| US12084503B2 (en) | Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatment | |
| JP6441792B2 (ja) | Ｅｇｆｒに結合する抗原結合蛋白質 | |
| JP2015518827A5 (OSRAM) | ||
| CN105120890B (zh) | 与ErbB3结合的抗原结合蛋白 | |
| JP2015520172A (ja) | Ｄｌｌ−４に結合する抗原結合蛋白質 | |
| CN104411332B (zh) | 与vegfr2结合的全人抗体 | |
| JP6388576B2 (ja) | Ｉｇｆ１ｒに結合する抗原結合タンパク質 |